CVE-2025-15653: Dräger Zeus Anesthesia Workstation USB Security Vulnerability

Technical summary

CVE-2025-15653 describes insufficient protection of USB interfaces on Dräger anesthesia delivery systems. The vulnerability stems from inadequate access controls on USB ports, enabling direct manipulation of device firmware or software components. An attacker with physical proximity can exploit this to modify the device's behavior, corrupt therapy-related functions, or establish persistence. When the affected workstation connects to a hospital network or Dräger Service Connect infrastructure, the compromised device becomes a potential vector for lateral movement and broader infrastructure compromise. The vulnerability is classified as CWE-668 (Exposure of Resource to Wrong Sphere).

Business impact

In a healthcare delivery context, this vulnerability poses a direct patient safety risk. Compromised anesthesia workstations could deliver incorrect therapy parameters, fail to monitor patient vitals correctly, or become unavailable during critical procedures. Beyond immediate bedside impact, network-connected devices create supply-chain and operational continuity risks. Hospital IT teams face potential downstream network intrusions if a Zeus workstation is leveraged as an entry point. For biomedical engineering and OR management, this requires rethinking physical security protocols around expensive, networked medical devices and introduces complexity into device maintenance and decommissioning procedures.

Affected systems

The vulnerability affects Dräger Zeus Infinity Empowered (Zeus IE) and Zeus RS C500 anesthesia workstations. No specific product versions, firmware versions, or patch cutoff dates are listed in the vulnerability advisory, necessitating direct consultation with Dräger for detailed impact scope and remediation guidance.

Exploitability

Exploitation requires physical access to the device (CVSS vector AV:P), which is present in hospital operating rooms, recovery areas, and equipment storage. No special privileges, authentication, or user interaction are needed once physical access is obtained. While the attack vector is not remote, the risk is material in healthcare environments where equipment is accessible to staff, contractors, and—in cases of inadequate physical security—unauthorized individuals. The attack complexity is low, making it straightforward to execute.

Remediation

Dräger has released or will release patches to restrict or protect USB interface functionality. Organizations should immediately contact Dräger technical support to identify applicable patches and firmware updates for their specific Zeus IE and RS C500 models and software versions. In parallel, implement compensating controls: restrict physical access to workstations via locked equipment cabinets or restricted-access ORs, disable non-essential USB ports, establish detailed equipment access logs, and conduct staff security awareness training on the risks of unauthorized device manipulation.

Patch guidance

Verify the applicable patch and firmware updates directly with Dräger or through your organization's biomedical equipment vendor/service partner. Patch deployment should be coordinated with clinical operations to ensure minimal downtime and validated functionality post-update. Before applying patches in production, test them in a non-clinical environment that mirrors your deployment. Document the patch version, deployment date, and all affected serial numbers for audit and compliance purposes.

Detection guidance

Monitor for physical tampering indicators: unexpected USB device activity, firmware hash changes, or unauthorized configuration alterations. If your workstations are networked, baseline their network behavior and alert on anomalous outbound connections or lateral scanning. Implement access logs on any locked equipment enclosures where Zeus workstations are stored. Conduct periodic integrity checks on device firmware (compare against known-good baselines provided by Dräger). If you maintain device audit logs, review them for evidence of configuration changes or unauthorized access attempts. Consider implementing device certificates or cryptographic signatures to verify firmware authenticity.

Why prioritize this

Although the CVSS score of 6.8 is 'Medium,' this vulnerability merits high prioritization in healthcare settings because it directly threatens patient safety, affects critical life-support equipment, and exploits a physical vector that is difficult to eliminate in real-world hospital workflows. The risk is not mitigated by network segmentation alone and affects therapy delivery integrity—a core function of the device. Even low-probability physical access exploits carry disproportionate consequence in clinical contexts. Prioritize patching based on device location and frequency of use.

Risk score, explained

The CVSS 3.1 score of 6.8 (Medium) reflects the physical access requirement (AV:P), which reduces the attack surface compared to networked exploits. However, the impact metrics are high across confidentiality, integrity, and availability (C:H/I:H/A:H), indicating that a successful compromise fully impacts all three security properties. The score appropriately penalizes the physical access requirement but does not discount the severity of medical device compromise. In healthcare risk modeling, this score should be elevated contextually to account for patient harm potential and the difficulty of detecting post-exploitation device compromise.

Frequently asked questions